Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrienne H Long

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Oncoimmunology|June 5, 2013
Lessons learned from a highly-active CD22-specific chimeric antigen receptorAdrienne H Long, Waleed M Haso, Rimas J Orentas
Pediatric Blood & Cancer|May 15, 2025
Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and ManagementAdrienne H Long, Catherine Aftandilian, Sara Barmettler, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 17, 2022
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back AgainAdrienne H Long, Daniel A Morgenstern, Amaury Leruste, et al.
Pediatric Blood & Cancer|February 4, 2025
COVID-19 Vaccine Response in Pediatric Oncology PatientsBrittni Kam, Yiwen Wang, FeiFei Qin, et al.
Pediatrics|June 23, 2019
Hypotonia and Lethargy in a Two-Day-Old Male InfantAdrienne H Long, Jennifer G Fiore, Riaz Gillani, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Fetal Thymic Expression Defines the Immunogenicity of Tumor Associated AntigensAdrienne H Long, Kaitlyn R Tooker, Nicholas M Pathoulas, et al.
Kidney International Reports|September 22, 2025
The Immune Microenvironment of Transplant GlomerulitisNathan A Bracey, Jonathan S Maltzman, Adrienne H Long, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.
Frontiers in Oncology|December 16, 2022
Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patientsAgnes Reschke, Rebecca M Richards, Stephanie M Smith, et al.
Cancer Immunology Research|August 24, 2016
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for SarcomasAdrienne H Long, Steven L Highfill, Yongzhi Cui, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Oncoimmunology|June 5, 2013
Lessons learned from a highly-active CD22-specific chimeric antigen receptorAdrienne H Long, Waleed M Haso, Rimas J Orentas
Pediatric Blood & Cancer|May 15, 2025
Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and ManagementAdrienne H Long, Catherine Aftandilian, Sara Barmettler, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 17, 2022
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back AgainAdrienne H Long, Daniel A Morgenstern, Amaury Leruste, et al.
Pediatric Blood & Cancer|February 4, 2025
COVID-19 Vaccine Response in Pediatric Oncology PatientsBrittni Kam, Yiwen Wang, FeiFei Qin, et al.
Pediatrics|June 23, 2019
Hypotonia and Lethargy in a Two-Day-Old Male InfantAdrienne H Long, Jennifer G Fiore, Riaz Gillani, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Fetal Thymic Expression Defines the Immunogenicity of Tumor Associated AntigensAdrienne H Long, Kaitlyn R Tooker, Nicholas M Pathoulas, et al.
Kidney International Reports|September 22, 2025
The Immune Microenvironment of Transplant GlomerulitisNathan A Bracey, Jonathan S Maltzman, Adrienne H Long, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 6, 2017
Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma KinaseAlec J Walker, Robbie G Majzner, Ling Zhang, et al.
Frontiers in Oncology|December 16, 2022
Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patientsAgnes Reschke, Rebecca M Richards, Stephanie M Smith, et al.
Cancer Immunology Research|August 24, 2016
Reduction of MDSCs with All-trans Retinoic Acid Improves CAR Therapy Efficacy for SarcomasAdrienne H Long, Steven L Highfill, Yongzhi Cui, et al.
Pageof 2